Solving Patient Matching in Rare Disease Trials

One of the most persistent barriers in rare disease drug development isn’t the science — it’s identifying and reaching the small number of patients who could benefit from emerging therapies. Without solving this, even the most promising innovations risk never reaching the people who need them most. In our latest podcast episode, we explore how the industry can better connect patients to clinical trials — and why this is critical to accelerating progress in rare disease. We’re delighted to welcome Dr Jennifer Levin, CEO of Medzown, who shares how her team is working to redefine the healthcare ecosystem by improving patient access to advanced therapies and clinical trials across cancer, rare, and complex diseases. If you’re working in clinical development, patient recruitment, or rare disease, this is a conversation worth your time.

You can listen to Solving Patient Matching in Rare Disease Trials online on Radio and Podcast. Open the player on this page to stream the available audio.

Solving Patient Matching in Rare Disease Trials is an episode from Rare Disease, Cell & Gene Therapy Monthly RoundUp by Partners4Access.

This episode is 00:33:36 long.

This episode was published on Apr 29, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Rare Disease, Cell & Gene Therapy Monthly RoundUp when more episodes are available from the podcast feed.